The anticancer and anti-metastatic properties of quercetin-zinc complex (Q-ZnCPX) were demonstrated via the reduction of migratory abilities and invasiveness of BFTC-905 human bladder cancer cells in vitro by the regulation of AKT and MT1-MMP, genes associated with tumor progression. This evidence concerns the gene AKT1 and urinary bladder cancer.